Efficacy and safety evaluation of omalizumab in the treatment of moderate-to-severe allergic asthma

doi:10.3969/j.issn.1672-3384.2023.09.010

ZHANG Yi, HAN Jia-lun, YU Xiao-jia, LI Bo-yu, CHEN Gang, ZHENG Yun-ying, AN Zhuo-ling

Clinical Medication Journal ›› 2023, Vol. 21 ›› Issue (9) : 51-55.

PDF(414 KB)

Clinical Medication Journal ›› 2023, Vol. 21 ›› Issue (9) : 51-55. DOI: 10.3969/j.issn.1672-3384.2023.09.010

Original Article

Efficacy and safety evaluation of omalizumab in the treatment of moderate-to-severe allergic asthma

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2023, 21(9): 51-55 https://doi.org/10.3969/j.issn.1672-3384.2023.09.010

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(414 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2023-07-20	2023-09-23
Issue Date
2023-09-23

Please choose a citation manager

Content to export